Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6602911rdf:typepubmed:Citationlld:pubmed
pubmed-article:6602911lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6602911lifeskim:mentionsumls-concept:C0038317lld:lifeskim
pubmed-article:6602911lifeskim:mentionsumls-concept:C0018120lld:lifeskim
pubmed-article:6602911lifeskim:mentionsumls-concept:C0033308lld:lifeskim
pubmed-article:6602911lifeskim:mentionsumls-concept:C0205065lld:lifeskim
pubmed-article:6602911lifeskim:mentionsumls-concept:C0016434lld:lifeskim
pubmed-article:6602911lifeskim:mentionsumls-concept:C0038302lld:lifeskim
pubmed-article:6602911lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:6602911lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6602911lifeskim:mentionsumls-concept:C0205087lld:lifeskim
pubmed-article:6602911pubmed:issue1lld:pubmed
pubmed-article:6602911pubmed:dateCreated1983-8-11lld:pubmed
pubmed-article:6602911pubmed:abstractTextThe dominant follicle at the late follicular phase was obtained from a human ovary, the follicular wall was homogenized and centrifuged at 800 g. Then, the supernatant fluid was incubated with [14C]-progesterone and the radioactive products were quantitated. 17-Hydroxyprogesterone, 16 alpha-hydroxyprogesterone and androstenedione were identified under the present experimental conditions. The apparent KM value of the 17 alpha-hydroxylase toward progesterone was 0.19 +/- 0.01 microM. Various ovarian steroids (17-hydroxyprogesterone, 20 alpha-hydroxy-4-pregnen-3-one. 16 alpha-hydroxyprogesterone, androstenedione, testosterone, estrone and estradiol-17 beta) were tested for their effects on this hydroxylase activity. Among them, 20 alpha-hydroxy-4-pregnen-3-one and 17-hydroxyprogesterone inhibited on the enzyme activity, significantly. They acted competitively and their Ki values were 0.23 microM for 20 alpha-hydroxy-4-pregnen-3-one and 0.54 microM for 17-hydroxyprogesterone.lld:pubmed
pubmed-article:6602911pubmed:languageenglld:pubmed
pubmed-article:6602911pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6602911pubmed:citationSubsetIMlld:pubmed
pubmed-article:6602911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6602911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6602911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6602911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6602911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6602911pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6602911pubmed:statusMEDLINElld:pubmed
pubmed-article:6602911pubmed:monthJanlld:pubmed
pubmed-article:6602911pubmed:issn0022-4731lld:pubmed
pubmed-article:6602911pubmed:authorpubmed-author:SandRRlld:pubmed
pubmed-article:6602911pubmed:authorpubmed-author:AraiKKlld:pubmed
pubmed-article:6602911pubmed:authorpubmed-author:OkinagaSSlld:pubmed
pubmed-article:6602911pubmed:issnTypePrintlld:pubmed
pubmed-article:6602911pubmed:volume18lld:pubmed
pubmed-article:6602911pubmed:ownerNLMlld:pubmed
pubmed-article:6602911pubmed:authorsCompleteYlld:pubmed
pubmed-article:6602911pubmed:pagination55-8lld:pubmed
pubmed-article:6602911pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:meshHeadingpubmed-meshheading:6602911-...lld:pubmed
pubmed-article:6602911pubmed:year1983lld:pubmed
pubmed-article:6602911pubmed:articleTitleEffects of ovarian steroids on the 17 alpha-hydroxylase activity toward progesterone in a human ovarian follicle at the late follicular phase.lld:pubmed
pubmed-article:6602911pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6602911pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed